U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 911 - 920 of 13362 results

Status:
Possibly Marketed Outside US
Source:
Experior by Elanco’s former parent company, Eli Lilly
Source URL:

Class (Stereo):
CHEMICAL (ABSOLUTE)



Lubabegron was initially studied in the Eli Lilly’s lab for potential applications in human health. The drug is a beta-adrenergic agonist that has the effect of increasing the breakdown of fats and increasing energy expenditure in cells. Lubabegron is the first animal drug that was approved to reduce ammonia gas emissions from an animal or its waste. These ammonia gasses can come from many sources and can affect the health of people, animals and the environment.
Status:
Possibly Marketed Outside US
Source:
NARON ACE by Lundbeck
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)

Conditions:

Ethenzamide is an anti-inflammatory agent that was used for the treatment of common cold in Japan (in combinations with other NSAIDs).
Status:
Possibly Marketed Outside US
Source:
RELIEF AND NATURE TOOTHPAST E JASMINE MINT by NATURE REPUBLIC CO., LTD.
(2018)
Source URL:
First approved in 2018
Source:
RELIEF AND NATURE TOOTHPAST E JASMINE MINT by NATURE REPUBLIC CO., LTD.
Source URL:

Class (Stereo):
CHEMICAL (ACHIRAL)

Status:
Possibly Marketed Outside US
First approved in 2018

Class (Stereo):
CHEMICAL (RACEMIC)